Suchergebnisse - "Rodriguez, Cesar"

PubPharm (568)

41

Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma

enthalten in: Journal of the advanced practitioner in oncology | 2023

von Rodriguez, C. | Catamero, D.

42

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

enthalten in: Blood advances | 2023

von Mouhieddine, T. | Van Oekelen, O. | Melnekoff, D. | +19

43

Trial designs and endpoints for immune therapies in multiple myeloma

enthalten in: American journal of hematology | 2023

von Lancman, G. | Moshier, E. | Cho, H. | +8

44

Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma : Findings from the MASTER and GRIFFIN Trials

enthalten in: Transplantation and cellular therapy | 2023

von Chhabra, S. | Callander, N. | Watts, N. | +34

45

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer : Results of the KARMA Dx Study

enthalten in: Cancers | 2023

von Llombart-Cussac, A. | Anton-Torres, A. | Rojas, B. | +9

46

Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Etifa, P. | Rodríguez, C. | Harmanus, C. | +9

47

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

enthalten in: Blood | 2023

von Van Oekelen, O. | Nath, K. | Mouhieddine, T. | +20

48

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Straus, W. | Urdaneta, V. | Esposito, D. | +4

49

Operando DRIFT-MS for studying the oxidative steam reforming of ethanol (OSRE) reaction

enthalten in: MethodsX | 2023

von Rodríguez, C. | Moreno, S. | Molina, R.

50

A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel

enthalten in: Frontiers in pharmacology | 2023

von Amaya-Rodriguez, C. | Carvajal-Zamorano, K. | Bustos, D. | +2